Showing 411-420 of 7444 results for "".
Customize Online Content to Suit Your Target Audience
https://practicaldermatology.com/topics/practice-management/customize-online-content-to-suit-your-target-audience/21256/You can generate maximum impact for your practice when you create customized content with a sharp focus on your target audience.Key Tax Mistakes to Avoid
https://practicaldermatology.com/topics/practice-management/key-tax-mistakes-to-avoid/21260/How a common tax mistake could be costing you thousands annually.Ask an Expert: Sheila Fallon Friedlander, MD on the Molluscum Pipeline
https://practicaldermatology.com/topics/general-topics/ask-an-expert-sheila-fallon-friedlander-md-on-the-molluscum-pipeline/19006/Sheila Fallon Friedlander, MD talks to host Adam Friedman, MD about the pipeline of treatments for molluscum in pediatric patients. From NewDermMD.Allergan Strikes $66 Billion Deal with Actavis
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-allergan-strikes-66-billion-deal-with-actavis/19021/In this edition of DermWireTV, host Ranna Jaraha discusses this week's blockbuster merger deal between Allergan and Actavis. Also featured in this edition is a new report detailing the rising costs of treating skin cancer, and high recognition for a dermatologic device manufacturer.Acquiring An Education In Cosmetic Dermatology
https://practicaldermatology.com/topics/practice-management/acquiring-an-education-in-cosmetic-dermatology/19024/With many residency programs not emphasizing cosmetic dermatology, Kristina Goldenberg, MD gives advice on how to be proactive in achieving an education in aesthetics.Home Devices: Do They Actually Work?
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/home-devices-do-they-actually-work/21334/Although home devices may appeal to patients due to their convenience, often they fall short when it comes to sound science and optimal outcomes.Allergan Commemorates 25th Anniversary of the First Two Approved Uses of BOTOX® (onabotulinumtoxinA)
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/allergan-commemorates-25th-anniversary-of-the-first-two-approved-uses-of-botox-onabotulinumtoxina-/19136/Allergan, Inc. (NYSE: AGN) today announced the launch of a video recognizing the physician pioneers and patient communities who contributed to the development of BOTOX® (onabotulinumtoxinA), one of the most recognized pharmaceutical brands in the United States. The video kicks off a year-long campaiDermwireTV — Sun Rises, ICD-10 is Delayed…Again
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-mdash-sun-rises-icd-10-is-delayed-again/19139/In this week's DermwireTV, Sun acquires Ranbaxy, ICD-10 gets unexpectedly delayed, and Murad Alam recaps the ASLMS conference.ARTAS in Practice
https://practicaldermatology.com/topics/practice-management/artas-feinberg/19191/Dr. Feinberg describes how he incorporated the ARTAS Robotic Procedure into his practice.Biosimilar Medicines in Dermatology: Key Aspects
https://practicaldermatology.com/topics/psoriasis/biosimilar-medicines-in-dermatology-key-aspects/22929/After the recent enactment of a specific approval pathway for biosimilars and publication of the first draft guidelines on biosimilar product development by the FDA, biosimilars are expected to be available in the US soon.